TOX and cancer: To uncover potential features of CD4+ T-cell dysfunction in cancer and parallels with CD8+ T-cell exhaustion, we used the same marker profiles to investigate CD4+ T-cell subsets, which were identified by the expression of Tcf1/7 and TOX, respectively [10, 42].